ImmunityBio Files 8-K: Regulation FD & Exhibits
Ticker: IBRX · Form: 8-K · Filed: 2026-04-06T08:03:17-04:00
Sentiment: neutral
Topics: regulation-fd, filing, exhibit
Related Tickers: IBIO
TL;DR
IBIO filed an 8-K on 4/6/26 - check EX-99.1 for Reg FD info.
AI Summary
ImmunityBio, Inc. filed an 8-K on April 6, 2026, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing includes an exhibit (EX-99.1) which likely contains important information for investors, though the specific details of the disclosure are not provided in the text.
Why It Matters
This 8-K filing indicates ImmunityBio is disclosing material information to the public, which could impact its stock price and investor decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant news, but without knowing the content of the exhibit, the risk level is moderate.
Key Numbers
- 26061 — 8-K Document Size (Size of the main 8-K filing in KB.)
- 20447 — EX-99.1 Document Size (Size of Exhibit 99.1 in KB, likely containing the core disclosure.)
Key Players & Entities
- ImmunityBio, Inc. (company) — Filer of the 8-K
- 0001326110 (company) — CIK number for ImmunityBio, Inc.
- 2026-04-06 (date) — Filing date and period of report
- EX-99.1 (document) — Exhibit containing likely disclosure
FAQ
What specific information is disclosed in Exhibit 99.1?
The provided text does not detail the content of Exhibit 99.1, only that it is part of the 8-K filing.
What is the purpose of a Regulation FD Disclosure?
Regulation FD (Fair Disclosure) requires public companies to disclose material non-public information to the public in a broad and non-exclusionary manner.
What are the business activities of ImmunityBio, Inc. based on the SIC code?
ImmunityBio, Inc. is classified under SIC code 2836, which pertains to Biological Products (excluding diagnostic substances).
When was the filing accepted by the SEC?
The filing was accepted on April 6, 2026, at 08:03:17.
What is the mailing and business address for ImmunityBio, Inc.?
The mailing and business address for ImmunityBio, Inc. is 3530 JOHN HOPKINS COURT, SAN DIEGO CA 92121.
From the Filing
EDGAR Filing Documents for 0001193125-26-142932 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-142932 Filing Date 2026-04-06 Accepted 2026-04-06 08:03:17 Documents 13 Period of Report 2026-04-06 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d70606d8k.htm iXBRL 8-K 26061 2 EX-99.1 d70606dex991.htm EX-99.1 20447 6 GRAPHIC g70606g0406080032556.jpg GRAPHIC 3849 Complete submission text file 0001193125-26-142932.txt 169590 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20260406.xsd EX-101.SCH 2860 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20260406_lab.xml EX-101.LAB 17233 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20260406_pre.xml EX-101.PRE 10818 16 EXTRACTED XBRL INSTANCE DOCUMENT d70606d8k_htm.xml XML 3501 Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235 ImmunityBio, Inc. (Filer) CIK : 0001326110 (see all company filings) EIN. : 431979754 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 26839604 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)